Compare Bajaj Finserv Healthcare Fund vs UTI Healthcare Fund
Bajaj Finserv Healthcare Fund
UTI Healthcare Fund
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹500
₹500
Expense Ratio
2.59
2.21
NAV
₹11.99
₹344.41
Fund Started
06 Dec 2024
01 Aug 2005
Fund Size
₹405.91 Cr
₹1443.57 Cr
Exit Load
1% for redemption within 3 Months
Exit load of 1% if redeemed within 30 days.
1 Year
22.24%
16.98%
3 Year
-
23.35%
5 Year
-
15.23%
Equity
96.58%
97.08%
Cash
2.27%
2.90%
Top 10 Holdings
Divi's Laboratories Ltd. | 9.67% |
Sun Pharmaceutical Industries Ltd. | 8.87% |
Piramal Pharma Ltd. | 6.60% |
Apollo Hospitals Enterprise Ltd. | 6.50% |
Aurobindo Pharma Ltd. | 6.13% |
Rubicon Research Ltd. | 6.01% |
Torrent Pharmaceuticals Ltd. | 5.48% |
Neuland Laboratories Ltd. | 4.42% |
Emcure Pharmaceuticals Ltd. | 4.37% |
Max Healthcare Institute Ltd. | 3.80% |
Sun Pharmaceutical Industries Ltd. | 8.71% |
Divi's Laboratories Ltd. | 5.57% |
Ajanta Pharma Ltd. | 4.80% |
Caplin Point Laboratories Ltd. | 3.95% |
Lupin Ltd. | 3.59% |
Gland Pharma Ltd. | 3.56% |
Apollo Hospitals Enterprise Ltd. | 3.46% |
Dr. Reddy's Laboratories Ltd. | 3.10% |
Alkem Laboratories Ltd. | 3.10% |
Global Health Ltd. | 2.81% |
Name
-
-
Start Date
-
-
Description
The Scheme seeks to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
06 Dec 2024
01 Aug 2005
